Deeptech in Glioblastoma
- Jan 22
- 1 min read
On January 22, 2026, the PSCC and Brain&Mind jointly brought together, at The Hive building on Campus Grand Parc (Villejuif), a broad range of stakeholders involved in innovation in glioblastoma — clinicians, researchers, biotech, medtech and pharmaceutical companies, patients and patient representatives, as well as institutional stakeholders. The objective of this event was to take stock of the latest advances in glioblastoma, to discuss future perspectives from technological, regulatory and methodological standpoints, and to foster new synergies across the ecosystem.
Find a summary of the event here:
Full reports and presentations are available only to PSCC Connect members or upon request.
